TETI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 12.199
NA - Nord America 10.224
AS - Asia 5.725
SA - Sud America 1.902
AF - Africa 161
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 30.232
Nazione #
US - Stati Uniti d'America 10.054
RU - Federazione Russa 6.093
SG - Singapore 2.306
CN - Cina 1.961
BR - Brasile 1.675
IE - Irlanda 1.414
SE - Svezia 1.256
IT - Italia 702
DE - Germania 661
HK - Hong Kong 553
UA - Ucraina 553
FR - Francia 464
FI - Finlandia 324
VN - Vietnam 272
GB - Regno Unito 256
PL - Polonia 220
IN - India 130
BD - Bangladesh 100
AR - Argentina 84
CA - Canada 68
IQ - Iraq 54
CZ - Repubblica Ceca 52
MX - Messico 51
TR - Turchia 50
BE - Belgio 49
ZA - Sudafrica 46
EC - Ecuador 37
MA - Marocco 36
PK - Pakistan 36
JP - Giappone 32
UZ - Uzbekistan 31
CO - Colombia 29
ES - Italia 28
NL - Olanda 26
AT - Austria 23
VE - Venezuela 23
ID - Indonesia 22
KE - Kenya 19
CL - Cile 18
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 17
TN - Tunisia 17
PH - Filippine 16
JO - Giordania 14
AZ - Azerbaigian 12
EG - Egitto 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
DZ - Algeria 11
BG - Bulgaria 9
IR - Iran 9
LT - Lituania 9
NP - Nepal 9
PY - Paraguay 9
CR - Costa Rica 8
IL - Israele 8
JM - Giamaica 8
KG - Kirghizistan 8
KZ - Kazakistan 8
PE - Perù 8
PS - Palestinian Territory 8
AL - Albania 7
AU - Australia 7
MY - Malesia 7
PT - Portogallo 7
RO - Romania 7
CH - Svizzera 6
EU - Europa 6
LV - Lettonia 6
OM - Oman 6
PA - Panama 6
AM - Armenia 5
HN - Honduras 5
SN - Senegal 5
AO - Angola 4
BN - Brunei Darussalam 4
BO - Bolivia 4
GT - Guatemala 4
LB - Libano 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GR - Grecia 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AG - Antigua e Barbuda 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
KR - Corea 2
LK - Sri Lanka 2
Totale 30.202
Città #
Moscow 1.856
Dublin 1.412
Singapore 1.256
Ashburn 1.225
Dallas 1.220
Chandler 1.128
Jacksonville 1.121
Nyköping 687
Hong Kong 551
San Jose 537
Beijing 532
Shenzhen 469
Messina 288
The Dalles 283
Dearborn 249
Los Angeles 248
Princeton 243
Cambridge 235
Medford 235
Lauterbourg 221
Warsaw 214
Boardman 213
Des Moines 196
Ann Arbor 188
Buffalo 143
New York 123
Munich 115
São Paulo 115
Council Bluffs 89
Ho Chi Minh City 82
Woodbridge 80
Bremen 70
Tianjin 69
Hanoi 61
Shenyang 60
Wilmington 57
Jinan 55
Orem 53
Belo Horizonte 50
Brussels 48
San Mateo 47
Brno 46
Guangzhou 45
Helsinki 43
Chennai 41
Redondo Beach 39
Turku 39
Frankfurt am Main 35
Rio de Janeiro 35
Santa Clara 35
Nanjing 34
Pune 32
Milan 31
Brasília 30
Lancaster 30
Nuremberg 30
Haikou 29
Tashkent 29
Tokyo 29
Rome 27
Seattle 27
Brooklyn 26
Hebei 26
Ningbo 25
Shanghai 25
Houston 24
Johannesburg 24
Zhengzhou 24
Dong Ket 23
Baghdad 22
Norwalk 22
Curitiba 21
Düsseldorf 21
London 21
Montreal 21
Stockholm 21
Denver 20
Dhaka 20
Porto Alegre 20
Mumbai 19
Amsterdam 18
Taiyuan 18
Goiânia 17
Hangzhou 17
Poplar 17
Ribeirão Preto 17
Campinas 16
Phoenix 16
Taizhou 16
Catania 15
Guayaquil 15
Chicago 14
Nairobi 14
Vienna 14
Washington 14
Amman 13
Boston 13
Guarulhos 13
Haiphong 13
Mexico City 13
Totale 17.538
Nome #
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. 618
ATTIVAZIONE DI NLRP3 IMFLAMMASOMA NEL CORSO DELLE INFEZIONI SOSTENUTE DAGLI STREPTOCOCCHI DI GRUPPO B 276
Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform 246
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. 237
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci 234
Analysis of the secretome of the group B Streptococcus 219
Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries 217
Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology 214
The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci 212
A new surface protein of Streptococcus suis identified by proteomics 204
Analysis of the Streptococcus agalactiae exoproteome. 204
Anti-idiotypic B5 single chain variable fragment [synthetic construct]. 203
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection 202
Activation of the NLRP3 inflammasome by group B streptococci. 199
Anti-idiotypic G1 single chain variable fragment [synthetic construct]. 197
Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor 194
Approccio proteomico per l’analisi comparativa del secretoma di coltura di S. agalactiae, ceppo Nem316 192
Essential role of interleukin-1 signaling in host defenses against group B streptococcus 191
CXCL1/2 chemokines are newly synthesized by neutrophils and released at high levels after recognition of live Group B Streptococcus by means of endosomal Toll-like receptors 191
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. 188
Caratterizzazione molecolare di glicoproteine criptococciche capaci di indurre risposte umorali. 187
Characterization of two novel Cryptococcal mannoproteins recognized by immune sera 187
Anti-idiotypic vaccination against group B streptococci 183
Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4 181
beta(2) integrins are involved in cytokine responses to whole Gram-positive bacteria 181
Neutrophils Enhance Their Own Influx to Sites of Bacterial Infection via Endosomal TLR-Dependent Cxcl2 Production 180
The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/αvintegrin axis 176
NEUTROPHILS PRODUCE HIGH LEVELS OF CHEMOKINES (CXCL1/2) AFTER SENSING GROUP B STREPTOCOCCUS THROUGH ENDOSOMAL TLRS 174
“Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor” 173
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes 173
Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library. 173
Age-related sensitivity of neonatal mice to toxicity induced by heat-killed group B streptococci. 173
Bacteroides fragilis lipopolysaccharide activates cells via CD14/MD2/TLR4 171
Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization 170
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection 170
Attivazione dell'inflammasoma da parte di S.pneumoniae 170
Costruzione e screening di librerie “lambda display” da genoma completo di streptococchi patogeni per l’identificazione di prodotti genici che interagiscono con i tessuti dell’ospite. 169
Plasminogen- and Fibronectin–Binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells. 167
The IL-1b/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection 167
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells 166
Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease 165
NEUTROPHILS ARE MAINLY RESPONSIBLE FOR IL-1Β PRODUCTION DURING GROUP B STREPTOCOCCUS INFECTION 165
CELL ACTIVATION INDUCED BY LIPOTEICHOIC ACID AND POLYSACCHARAIDES FRM STREPTOCOCCI. 164
MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans 164
Protective activity of a protein fragment identified by the screening of a Streptococcus pneumoniae phage-displayed genomic library 164
PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of Group B Streptococcus 164
Identificazione mediante “Phage Display” diframmenti biologicamente attivi della fibrinogenbinding protein A (FbsA) di Streptococcus agalactiae. 163
Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs 163
A meeting of mimics. 162
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria 162
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease 161
AGE-RELATED MORTALITY AND ADHERENT SPLENIC CELL MEDIATOR PRODUCTION TO ENDOTOXIN IN THE RAT 160
Isolation of bacterial RNA from infected host tissues: application for transcriptomic studies of group B streptococci 160
Immunogenic mimics of Brucella lipopolysaccharide epitopes 159
Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade 159
Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen- Specific Libraries 158
La proteina FbsA di Streptococcus agalactiae è unimportante fattore di virulenza 157
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice 157
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. 156
Ruolo dell'interluchina 18 nelle infezioni da streptococco di gruppo B. 153
ANTI-LIPOTEICHOIC ACID ANTIBODIES ENHANCE RELEASE OF CYTOKINES BY MONOCYTES SENSITIZED WITH LIPOTEICHOIC ACID 153
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 153
Evaluation of a rapid method to exclude the presence of certain enteric pathogens in stool specimens. 152
Proceedings of the second Centro 3R Annual Meeting | September 30th - October 1st of Biomedical Science and Engineering. Vol. 4 No. s1 (2021) 152
Constitutive activation of two-component systems reveals regulatory network interactions in Streptococcus agalactiae 151
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components 151
Effects of taxol on TNF-alpha and IL-6 production by human peripheral blood cells. 151
The Phagocyte, Metchnikoff, and the Foundation of Immunology 150
Uso del “phage display”per caratterizzare ilrepertorio anticorpale indotto da vaccinazione. 145
Role of TLR13 in innate immune recognition of group B streptococci 145
BETA-LACTAM ANTIBIOTICS (AZTREONAM, AMPICILLIN, CEFAZOLIN AND CEFTAZIDIME) IN THE CONTROL AND ERADICATION OF SALMONELLA- TYPHIMURIUM IN NATURALLY RESISTANT AND SUSCEPTIBLE MICE 144
Virus ed infezioni alimentari: il caso dell’epatite A 144
Immunoprotective activity of a Streptococcus pneumoniae protein identified by phage display. 144
Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant 143
Combating antibiotic resistance in S. pneumoniae infections: identification of pneumolysin binding peptides 143
Effects of anti-cytokine treatments in neonatal sepsis models 142
Plasminogen binding and immunoprotective properties of the Mk-rich domain of PbsP, a cell wall protein from Streptococcus agalactiae 142
Role of host's immune response in infections caused by Streptococcus pneumoniae 142
Identification and cloning of a cryptococcal deacetylase that produces protective immune responses 141
[Genetic techniques for the production of influenza vaccines (author's transl)]. 141
VACCINE FORMULATIONS COMPRISING ANTIIDIOTYPIC ANTIBODIES WHICH IMMUNOLOGICALLY MIMIC GROUP B STREPTOCOCCAL CARBOHYDRATES 140
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 140
BENEFICIAL-EFFECTS OF INTERLEUKIN-6 IN NEONATAL MOUSE MODELS OF GROUP-B STREPTOCOCCAL DISEASE 140
Cross reattività di una lipoproteina di Neisseriameningitidis con la proteina legante il fattore H (fHbp) 139
[Echocardiographic size of the left atrium and pulmonary "capillary" pressure in different cardiopathies]. 137
Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates 136
Induction of bactericidal antibodies by DNA Immunization with peptide mimics of the meningococcal capsule 135
Selection of Neisseria meningitidis group B antigenic epitopes using lambda libraries. 135
Compositional analysis of the major capsular polysaccharides of Cryptococcus neoformans by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) 134
Plasminogen- and fibronectin–binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cell 134
Identification of fibrinogen binding protein fragments using genomic phage display libraries of Group B Streptococcus 134
[Refractory junctional tachycardia controlled by radio-frequency programmed stimulation in association with amiodarone treatment]. 134
Comparison of six systems for the identification of Enterobacteriaceae. 133
The dual role of innate immunity during influenza 133
Immunità protettiva indotta da una glutamina sintetasi di Cryptococcus neoformans 132
Vaccinazione anti-idiotipica a DNA per l'induzione di anticorpi diretti contro il polissacaride di batteri capsulati. 132
Pro-interleukin-1 beta processing in response to streptococci is totally caspase-1 dependent in vitro, but not in vivo. 132
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection 131
Caratterizzazione immunologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante “phage-display 130
[Pseudoischemic unstable T wave with familial incidence]. 128
Totale 16.963
Categoria #
all - tutte 95.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 0 91
2021/20221.600 18 259 16 34 37 11 114 76 17 192 288 538
2022/20234.266 341 348 178 388 412 408 58 243 1.712 19 115 44
2023/20241.456 86 159 526 86 105 212 7 58 2 33 16 166
2024/20254.594 79 53 81 289 140 161 89 1.123 1.191 258 367 763
2025/202613.413 550 885 1.098 717 1.070 3.202 1.622 1.646 1.709 493 292 129
Totale 30.413